Covid-19 vaccine AstraZeneca

Covid-19 Vaccine AstraZeneca

The University of Oxford partnered with the British-Swedish company AstraZeneca to develop and test a coronavirus vaccine known as ChAdOx1 nCoV-19 or AZD1222.

News

 * 3 Feb 2021, Politico.eu, Switzerland won’t authorize Oxford/AstraZeneca vaccine, citing lack of data: Swiss regulators first want to see data from large-scale human trials.
 * 2 Feb 2021, Politico.eu, France, Sweden, Poland: Oxford/AstraZeneca vaccine not for elderly: The French health authority cited insufficient data on the elderly to make a conclusion.
 * 29 Jan 2021, Politico.eu, EU approves Oxford/AstraZeneca vaccine but fails to erase doubts: German scientists stood by their call that there isn’t enough data to know whether use the vaccine in people over 65.